Life sciences companies often invoke the attorney-client privilege and work-product doctrine to withhold protected information during patent litigation. Properly withholding a company’s own information, while also identifying and challenging the other side’s improper withholding of information, requires a strong understanding of the rules and their nuances.
Companies should work from the earliest stages of product development to establish procedures for properly protecting documents and information under the attorney-client privilege and the work product doctrine. Failing to do so may lead to the regretful position of competitors gaining access to information they were never intended to have.
Please join us as we discuss the attorney-client privilege and the work-product doctrine in life sciences patent cases, including:
Moderator:
Megan L. Meyers
Speakers:
Barbara R. Rudolph, Ph.D.
Linda A. Wadler
Date:
Thursday, April 16, 2020
Time:
10:00 - 11:00 a.m. PDT
1:00 - 2:00 p.m. EDT
19:00 - 20:00 CEST
Scheduling Conflict? Finnegan records all hosted webinars. To view the recorded program, simply register for the webinar and you will receive an access link shortly after the live program is complete.
At the PTAB Blog
May 20, 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.